Cargando…
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
Artificial glycan holes on recombinant Env-based vaccines occur when a potential N-linked glycosylation site (PNGS) is under-occupied, but not on their viral counterparts. Native-like SOSIP trimers, including clinical candidates, contain such holes in the glycan shield that induce strain-specific ne...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804554/ https://www.ncbi.nlm.nih.gov/pubmed/33826885 http://dx.doi.org/10.1016/j.celrep.2021.108933 |
_version_ | 1784643097005654016 |
---|---|
author | Derking, Ronald Allen, Joel D. Cottrell, Christopher A. Sliepen, Kwinten Seabright, Gemma E. Lee, Wen-Hsin Aldon, Yoann Rantalainen, Kimmo Antanasijevic, Aleksandar Copps, Jeffrey Yasmeen, Anila Cupo, Albert Portillo, Victor M. Cruz Poniman, Meliawati Bol, Niki van der Woude, Patricia de Taeye, Steven W. van den Kerkhof, Tom L.G.M. Klasse, P.J. Ozorowski, Gabriel van Gils, Marit J. Moore, John P. Ward, Andrew B. Crispin, Max Sanders, Rogier W. |
author_facet | Derking, Ronald Allen, Joel D. Cottrell, Christopher A. Sliepen, Kwinten Seabright, Gemma E. Lee, Wen-Hsin Aldon, Yoann Rantalainen, Kimmo Antanasijevic, Aleksandar Copps, Jeffrey Yasmeen, Anila Cupo, Albert Portillo, Victor M. Cruz Poniman, Meliawati Bol, Niki van der Woude, Patricia de Taeye, Steven W. van den Kerkhof, Tom L.G.M. Klasse, P.J. Ozorowski, Gabriel van Gils, Marit J. Moore, John P. Ward, Andrew B. Crispin, Max Sanders, Rogier W. |
author_sort | Derking, Ronald |
collection | PubMed |
description | Artificial glycan holes on recombinant Env-based vaccines occur when a potential N-linked glycosylation site (PNGS) is under-occupied, but not on their viral counterparts. Native-like SOSIP trimers, including clinical candidates, contain such holes in the glycan shield that induce strain-specific neutralizing antibodies (NAbs) or non-NAbs. To eliminate glycan holes and mimic the glycosylation of native BG505 Env, we replace all 12 NxS sequons on BG505 SOSIP with NxT. All PNGS, except N133 and N160, are nearly fully occupied. Occupancy of the N133 site is increased by changing N133 to NxS, whereas occupancy of the N160 site is restored by reverting the nearby N156 sequon to NxS. Hence, PNGS in close proximity, such as in the N133-N137 and N156-N160 pairs, affect each other’s occupancy. We further apply this approach to improve the occupancy of several Env strains. Increasing glycan occupancy should reduce off-target immune responses to vaccine antigens. |
format | Online Article Text |
id | pubmed-8804554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-88045542022-02-01 Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike Derking, Ronald Allen, Joel D. Cottrell, Christopher A. Sliepen, Kwinten Seabright, Gemma E. Lee, Wen-Hsin Aldon, Yoann Rantalainen, Kimmo Antanasijevic, Aleksandar Copps, Jeffrey Yasmeen, Anila Cupo, Albert Portillo, Victor M. Cruz Poniman, Meliawati Bol, Niki van der Woude, Patricia de Taeye, Steven W. van den Kerkhof, Tom L.G.M. Klasse, P.J. Ozorowski, Gabriel van Gils, Marit J. Moore, John P. Ward, Andrew B. Crispin, Max Sanders, Rogier W. Cell Rep Article Artificial glycan holes on recombinant Env-based vaccines occur when a potential N-linked glycosylation site (PNGS) is under-occupied, but not on their viral counterparts. Native-like SOSIP trimers, including clinical candidates, contain such holes in the glycan shield that induce strain-specific neutralizing antibodies (NAbs) or non-NAbs. To eliminate glycan holes and mimic the glycosylation of native BG505 Env, we replace all 12 NxS sequons on BG505 SOSIP with NxT. All PNGS, except N133 and N160, are nearly fully occupied. Occupancy of the N133 site is increased by changing N133 to NxS, whereas occupancy of the N160 site is restored by reverting the nearby N156 sequon to NxS. Hence, PNGS in close proximity, such as in the N133-N137 and N156-N160 pairs, affect each other’s occupancy. We further apply this approach to improve the occupancy of several Env strains. Increasing glycan occupancy should reduce off-target immune responses to vaccine antigens. 2021-04-06 /pmc/articles/PMC8804554/ /pubmed/33826885 http://dx.doi.org/10.1016/j.celrep.2021.108933 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Derking, Ronald Allen, Joel D. Cottrell, Christopher A. Sliepen, Kwinten Seabright, Gemma E. Lee, Wen-Hsin Aldon, Yoann Rantalainen, Kimmo Antanasijevic, Aleksandar Copps, Jeffrey Yasmeen, Anila Cupo, Albert Portillo, Victor M. Cruz Poniman, Meliawati Bol, Niki van der Woude, Patricia de Taeye, Steven W. van den Kerkhof, Tom L.G.M. Klasse, P.J. Ozorowski, Gabriel van Gils, Marit J. Moore, John P. Ward, Andrew B. Crispin, Max Sanders, Rogier W. Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike |
title | Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike |
title_full | Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike |
title_fullStr | Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike |
title_full_unstemmed | Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike |
title_short | Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike |
title_sort | enhancing glycan occupancy of soluble hiv-1 envelope trimers to mimic the native viral spike |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804554/ https://www.ncbi.nlm.nih.gov/pubmed/33826885 http://dx.doi.org/10.1016/j.celrep.2021.108933 |
work_keys_str_mv | AT derkingronald enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT allenjoeld enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT cottrellchristophera enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT sliepenkwinten enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT seabrightgemmae enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT leewenhsin enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT aldonyoann enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT rantalainenkimmo enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT antanasijevicaleksandar enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT coppsjeffrey enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT yasmeenanila enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT cupoalbert enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT portillovictormcruz enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT ponimanmeliawati enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT bolniki enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT vanderwoudepatricia enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT detaeyestevenw enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT vandenkerkhoftomlgm enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT klassepj enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT ozorowskigabriel enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT vangilsmaritj enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT moorejohnp enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT wardandrewb enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT crispinmax enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike AT sandersrogierw enhancingglycanoccupancyofsolublehiv1envelopetrimerstomimicthenativeviralspike |